Jan A.C. Hontelez , Ineke T. Spruijt , Roel Bakker , Frank Cobelens , Connie Erkens , Susan van den Hof , Sake J. de Vlas
{"title":"荷兰高风险移民和寻求庇护者结核病感染筛查和治疗的成本效益:一项队列模型研究","authors":"Jan A.C. Hontelez , Ineke T. Spruijt , Roel Bakker , Frank Cobelens , Connie Erkens , Susan van den Hof , Sake J. de Vlas","doi":"10.1016/j.jiph.2025.102889","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>We evaluated the cost-effectiveness of TB infection (TBI) screening and TB preventive treatment (TPT) for immigrants, asylum seekers, and settled migrants in The Netherlands.</div></div><div><h3>Methods</h3><div>We used a deterministic cohort model that captures the natural history of TBI and TB disease for a migrant cohort in the country of origin (pre-entry) and in The Netherlands (post-entry). We fitted the pre-entry force of infection to Interferon Gamma Release Assay (IGRA) positivity rates from an implementation pilot study, and chest X-ray (CXR) positivity from the national entry-screening programme. We compared the costs per quality adjusted life year (QALY) gained for TBI screening with CXR screening over a 20-year time-horizon, accounting for parameter uncertainty by producing predictions for over 1000 unique parameter combinations that fit the data.</div></div><div><h3>Results</h3><div>TBI screening uniformly resulted in an increase in QALYs gained compared to current CXR-based screening policies. For immigrants, <10 % of parameter combinations predicted TBI entry screening to be more cost-effective than CXR screening under observed TPT completion rates (36 %). However, this changed to nearly 100 % of parameter combinations for immigrants coming from countries with a TB incidence of ≥100 per 100,000 when applying TPT completion rates as observed in asylum seekers (72 %). For asylum seekers, 100 % of parameter combinations predicted cost-effectiveness, while 0 % predicted TBI screening to be cost-effective among settled migrants.</div></div><div><h3>Conclusions</h3><div>TBI entry screening is a cost-effective alternative to CXR entry screening for immigrants and asylum seekers coming from high TB endemic countries, provided TPT completion is sufficiently high.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"18 10","pages":"Article 102889"},"PeriodicalIF":4.7000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cost-effectiveness of tuberculosis infection screening and treatment among high-tuberculosis risk immigrants and asylum seekers in The Netherlands: A cohort modelling study\",\"authors\":\"Jan A.C. Hontelez , Ineke T. Spruijt , Roel Bakker , Frank Cobelens , Connie Erkens , Susan van den Hof , Sake J. de Vlas\",\"doi\":\"10.1016/j.jiph.2025.102889\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>We evaluated the cost-effectiveness of TB infection (TBI) screening and TB preventive treatment (TPT) for immigrants, asylum seekers, and settled migrants in The Netherlands.</div></div><div><h3>Methods</h3><div>We used a deterministic cohort model that captures the natural history of TBI and TB disease for a migrant cohort in the country of origin (pre-entry) and in The Netherlands (post-entry). We fitted the pre-entry force of infection to Interferon Gamma Release Assay (IGRA) positivity rates from an implementation pilot study, and chest X-ray (CXR) positivity from the national entry-screening programme. We compared the costs per quality adjusted life year (QALY) gained for TBI screening with CXR screening over a 20-year time-horizon, accounting for parameter uncertainty by producing predictions for over 1000 unique parameter combinations that fit the data.</div></div><div><h3>Results</h3><div>TBI screening uniformly resulted in an increase in QALYs gained compared to current CXR-based screening policies. For immigrants, <10 % of parameter combinations predicted TBI entry screening to be more cost-effective than CXR screening under observed TPT completion rates (36 %). However, this changed to nearly 100 % of parameter combinations for immigrants coming from countries with a TB incidence of ≥100 per 100,000 when applying TPT completion rates as observed in asylum seekers (72 %). For asylum seekers, 100 % of parameter combinations predicted cost-effectiveness, while 0 % predicted TBI screening to be cost-effective among settled migrants.</div></div><div><h3>Conclusions</h3><div>TBI entry screening is a cost-effective alternative to CXR entry screening for immigrants and asylum seekers coming from high TB endemic countries, provided TPT completion is sufficiently high.</div></div>\",\"PeriodicalId\":16087,\"journal\":{\"name\":\"Journal of Infection and Public Health\",\"volume\":\"18 10\",\"pages\":\"Article 102889\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-07-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Infection and Public Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1876034125002382\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034125002382","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Cost-effectiveness of tuberculosis infection screening and treatment among high-tuberculosis risk immigrants and asylum seekers in The Netherlands: A cohort modelling study
Background
We evaluated the cost-effectiveness of TB infection (TBI) screening and TB preventive treatment (TPT) for immigrants, asylum seekers, and settled migrants in The Netherlands.
Methods
We used a deterministic cohort model that captures the natural history of TBI and TB disease for a migrant cohort in the country of origin (pre-entry) and in The Netherlands (post-entry). We fitted the pre-entry force of infection to Interferon Gamma Release Assay (IGRA) positivity rates from an implementation pilot study, and chest X-ray (CXR) positivity from the national entry-screening programme. We compared the costs per quality adjusted life year (QALY) gained for TBI screening with CXR screening over a 20-year time-horizon, accounting for parameter uncertainty by producing predictions for over 1000 unique parameter combinations that fit the data.
Results
TBI screening uniformly resulted in an increase in QALYs gained compared to current CXR-based screening policies. For immigrants, <10 % of parameter combinations predicted TBI entry screening to be more cost-effective than CXR screening under observed TPT completion rates (36 %). However, this changed to nearly 100 % of parameter combinations for immigrants coming from countries with a TB incidence of ≥100 per 100,000 when applying TPT completion rates as observed in asylum seekers (72 %). For asylum seekers, 100 % of parameter combinations predicted cost-effectiveness, while 0 % predicted TBI screening to be cost-effective among settled migrants.
Conclusions
TBI entry screening is a cost-effective alternative to CXR entry screening for immigrants and asylum seekers coming from high TB endemic countries, provided TPT completion is sufficiently high.
期刊介绍:
The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.
The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.
It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.